Peer Review reports
From: Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
Original Submission | ||
---|---|---|
5 Jan 2021 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
9 Jan 2021 | Reviewed | Reviewer Report |
26 Jan 2021 | Reviewed | Reviewer Report |
1 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
Resubmission - Version 3 | ||
1 Feb 2021 | Submitted | Manuscript version 3 |
7 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
Resubmission - Version 4 | ||
7 Feb 2021 | Submitted | Manuscript version 4 |
9 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
Resubmission - Version 5 | ||
9 Feb 2021 | Submitted | Manuscript version 5 |
24 Feb 2021 | Author responded | Author comments - Sung Kyu Hong |
Resubmission - Version 6 | ||
24 Feb 2021 | Submitted | Manuscript version 6 |
3 Mar 2021 | Reviewed | Reviewer Report |
5 Mar 2021 | Reviewed | Reviewer Report |
18 Mar 2021 | Author responded | Author comments - Sung Kyu Hong |
Resubmission - Version 7 | ||
18 Mar 2021 | Submitted | Manuscript version 7 |
Publishing | ||
26 Mar 2021 | Editorially accepted | |
5 Apr 2021 | Article published | 10.1186/s12894-021-00827-2 |
You can find further information about peer review here.